BSC Fights Bid To Block Thrombosis Info At Stent Trial

Law360, New York (October 8, 2007, 12:00 AM EDT) -- Boston Scientific Corp. is asking a court to reconsider its decision to preclude certain references to the increased risk of thrombosis posed by rival medical device maker Cordis Corp.'s Cypher heart stent at an upcoming trial in a patent infringement battle between the companies.

In court documents filed Monday in the U.S. District Court for the Northern District of California, Boston Scientific accused the Johnson & Johnson subsidiary of seeking to exclude evidence that its own products contain risks. Boston Scientific said that Cordis is simultaneously...
To view the full article, register now.